Registered number: 06641016
Charity number: 1126927
THE INTERNATIONAL SOCIETY FOR PEDIATRIC AND ADOLESCENT
DIABETES
(A Company Limited by Guarantee)
TRUSTEES. REPORT, INDEPENDENT EXAMINER'S REPORT AND FINANCIAL
STATEMENTS
FOR THE PERIOD ENDED 31 DECEMBER 2021
*ABIXV23U*
15112r2022
COMPANIES HOUSE
A19

THE INTERNATIONAL SOCIETY FOR PEDIATRIC AND ADOLESCENT DIABETES
IA Company Limited by Guarnntee}
CONTENTS
Page
Reference and Administrative Details of the Charity. its Trustees and Advlse
Trustees. Report
Independent Exafflinerfs Report
Statement of Financial kiivities
2-10
11-12
13
Balance Sheet
14
Statement of Cash Flows
15
Notes to th• Financial Statements
16-32

THE INTERNATIONAL SOCIETY FOR PEDIATRIC AND ADOLESCEirr DIABETES
IA Company Limited by Guarantee)
REFERENCE AND ADMINISTRATIVE DETAILS OF THE CHARITY. ITS TRUSTEES AND ADVISERS
FOR THE PERIOD ENDED 31 DECEMBER 2021
Trustees
PTofessN David Maahs. Secretary General IresKJned 16 October 20201
Professor Kim Donaghue, President (resigned 16 October 20201
Dr Lars KTogvold. Treasurer
Dr Carine de Beaufort PreS￿ent (appointed 16 October 20201
Dr Jamie Wood. Secretary General lapwinled 16 October 2020)
Company registered
number
08641016
Charity r8gl$tered
number
1126927
Registerèd office
Ellenborough House
Wellington Street
Che￿enharn
Gloucestershire
GL50 1YD
Management Company l K.l.T. Group GmbH
Principal Office
Company se¢retary
Dr Jamie Wood
Independent Examiner
Tara Weslcott FCCA. Crowe U.K. LLP
Fourth Floor
St James House
Sl James Squa
Cheltenham
GL50 3PR
Bankers
Commerzbank
Bedin-Gedathtniskirche
Kurfu'fslendamm 237
10719 Berlin
Germany
Lbyds Bank PIC
Rotunda
Montpellier
Cheltenham
Gloucestershire
GL50 1SH
Page 1

THE INTERNATIONAL SOCIETY FOR PEDIATRIC AND ADOLESCENT DIABETES
IA Company Limited by Guarantee)
TRUSTEES. REPORT
FOR THE PERIOD ENDED 31 DECEMBER 2021
The Tnjslees under Chanty Law, who are also Ihe Th"rectots under Company Law, present their report and the
financial 5talemenls of the Charty for the period ended 31 December 2021. This report has been prepared in
accordance with the special provisi￿$ rekts.ng to Companies subjed lo the small companies regime within Part
15 of the Compan￿$ Act 20(￿.
The Intemalional Souety for Ped[atr￿ and Adolescent Diabetes - ISPAD - is a Charitab￿ company, limrted by
guarantee. incorporated on 8 Juty 2008 (registration number 066410161 and registered as a charity on 25
November 2008 Icharity number 11269271.
STRUCTURE. GOVERNANCE AND MANAGEMENT
Govèming Document
The Intemalional S¢xiely for Pediatric and AdoFescent Diabetes {ISPAD or the SIX￿ty} is govemed by ((5
Memorandum and ArtKtes of Association dated 8 Juty 2008 {amended 28 October 20161," and the UK Charity
Governa￿e Code.
Prlnclpal Activity
The prinapal aclivrty of ISPAD is to improve the INes of children. adolescents and young adults with diabetes
worf￿.de, wh￿h is accomp115hed by providiry forums, both Wr￿en (gukletinesl and fa¢e-lo-face Iscienlrfic
meetings. science s¢hoDls for physicians and for all*d healthcare profesS￿nal$, and postgraduate courses). to
phys￿lan$ and healthcare professionals who prowde care for young people wi(h diabetes. To adVa￿e further
these aims. ISPAD advocates throughout the wortd for the appropriate Provision of medical care and assists
inlemalional organisalions and heatth servites in the delivery of crrtul diabetes self4are supplies. such as
insulin and glucose lest stn"ps. together with eduCat￿nal and promots'onal material for all children and
adolescents with diabetes.
Organisational Management
Each officer of the Chanty has a role and responsibilities that are enumerated in the goveming document. The
Society's focus on Sc￿nCe, Ad￿¢Y and EducatK)n is ensured by the officers of the Society who serve as
Trustees. They have the uttimate reSp￿s￿bIlIty for fiscal and other decisions in accordance with the
Memoranduffl and ArtKles of As5walion, and any bylaws. They consult wrth the advisory council composed of
members of the Society ele¢led each year al Ihe Annual Conference. Advisory council members are specifically
sought from different regions of the world so that they are represenlalive of the membership as a whole. The
advisory council formally meets wrth the board fv￿ce each year. Betsyeeft meetings infom7ation is exchar>ged by
e-mail and regular ccnference calls. The dissemination of inf0m8t￿n important issues doès not r*ed to waf(
for fonnal meetings.
The Trustees relain an ¢yganlsat￿nal management group {K.l.T_ Group GmbH, Berfin. Germany) who deal with
the day-to4ay activities of the Sc¢*ty and athses the Tru51ees in this regard. They have the ability lo allocate
their employees in any manner that best seNes the Soa"ety and are granted a I￿nSe to organi5e and manage
the Annual Conference. the venue for which is selected by the Execulive Board. K.l.T_ Group reviews the
locations. budgets and logist￿ for the Society and S￿n$ the contrads between the rnanagemenl group and
venues and exhibitors. K.l.T. Group also cc41aborates wrth and prowdes logislKal support to the local conveners
and inlefnalional Scientific Ctynmrttee, which creates the scienlrfic program and selects speakers.
The management group maintsins for the ￿ordS of daY4￿laY financ￿1 transactions and provides
reports to the Treasurer and other Trustees at regular intervals. K.l.T. Group processes receipts and transfers
funds from the Society's accounts Iu5ed for day-l￿aY activrt*s1 with the approval of the Treasurer, or the
Trustees as a whole, during Twstee meelings or after discussKins wilh Trustees. They or9anise the venue and
related activ￿e$ Directors, meetings. The Charity retains tr•)th an accounting fimi and soliciiors. These advise
the Trustees on govemance. legd. and financial issues.
Rgcruitment and Training of TN$tees
The Trustees of the Society are the curTent seNing officers of the Society. The Trustees are elected by the
Page 2

THE INTERNATIONAL SOCIETY FOR PEDIATRIC AND ADOLESCENT DIABETES
IA Company Limited by Guarantee)
TRUSTEES. REPORT ICONTINUEOI
FOR THE PERIOD ENDED 31 DECEMBER 2021
rnembers at the Annual Conference. The processes for nomination elect￿￿ of the Trustees are OLrtlined in
the Articles and Memorandum (amended 12 October 2012 to allow electronic voting). Trustees have been
membets of the Socth for many yeats and have contn"buted to the Society in many arenas., e.g., serving on the
Advisory coun￿1. organising one or more of the Annual Scientific meetings. $c￿nCe schools or poslgraduale
courses. Trustees have contributed to the soc￿$ efforts in Soenee. Educalion and A￿V¢￿¢y. which are the
pillals of the Sociely.
N￿Y elected Tru51ees spend one year as Tru5tee*kcl and attend the Boardrrru51ee meeting5 to gain
experience in the Societvs ath.vrt￿s'. charity governance. ffinance5, grant pro￿$s1n9/appT0ValS and other issues
involving the organisatKJn and wnning of the Society. Trustees musl be members in good standing of the Society
and have participated in the activitres in leadetship roles. They Teceive fomial infomation about the
role and responsibilrties of a Trustee. and undertake seff-paced leaming from documents available through the
Charity Commission. The year spent seNng as Twsteeolect alkhvs on the job expenence, guidance and
educali¢)n from the current Trustees prior to assuming the responsibilty of a Trustee.
Structure and Relalion$hlps
The TrusteeslBoard of Direclors communicate wrth each other (usually via email) almost daily on the
management and ￿1￿ction of the Charty. A ￿gUlar formal video conference meeting is arranged monthty
betsveen the Officers and the Administration Company.
The Trustees relain an organisational management group lo assist ￿th the actual day-to4ay management of
the Charity and the Board has diwt ¢)versight of their acliwlies. The Souety contracts with the management
group to organise and manage the Annual Conferenee. The management group also provide material support
for meetings. Ofganises Ihe Annual Report vthh the Trustees. wh￿h is prepared for distribution at the Annual
General Meeting land by e-mail to the enkn.re membership) and provKles a posl-conference report for the
.Truslees after the Annual Conference.
Fonnal management reports a￿ presenled to the Trustees at faC￿tt>faCe meetings at least tw'ce per year. A
wrrtten report is presented to the Trustees an(J membets al the Annual General Meetsng. Information is
exchanged by e-mail or telephone frequently on an 'as needed. ￿51$. Financi81 fftports a￿ given lo the
Treasuref (egularly. and the Tiuslees are updated regulady.
The Trustees. on behaw of the Society. have e$lablished a contract Wiley, the publisher of the Stxiety's
joumal, Pedialri¢ Diabetes. to provide subscriptions lo PedKitri¢ Diabetes to all ISPAD members. The Trustees,
on behalf of the Society. provide scientific oversKJhl and work Close￿ wlh the conveners on the program of the
Annual Cortference.
The Stxiety has established agreements of cooperation, colLqboratKJn and Memoranda of Understanding with
other Charities. companies and Medical Professional Organis8tsons with similar objectives and aims on a need's
basis.
The Trustees ¢￿tract for fxility space, aud*>visual supplies and support. and fcK#J for the Winter administration
meeting (usually held during the intemalional conference on Advanced Technobgie5 & Treatment5 for Diabete51
and the June meeting Usual￿ held during the Amer¢can Diabetes Associats"on Annual Scientific Meeting in the
United States.
The Trustees sel poI￿leS and guidelines for ¢xgani%ing and running the Annual Conference.
Rlsk MaDagemenl
By conlfactual agreement. the management group shares the finanaal risk for the Annual Conference, whieh
usualty attfacls al least 1.000 attendees from around the worfd. ISPAD maintains a subslanlial amount of
reserve funds and does not spend money unless convinced that so doing is consislenl with the mission of
ISPAD. likely to be benefual and will not deplete its reSe￿e$.
Page 3

THE INTERNATIONAL SOCIEff FOR PEDIATRIC AND ADOLESCENT DIABETES
IA Company Limited by Guarnntee)
TRUSTEES. REPORT ICONTINUEDI
FOR THE PERIOD ENDED 31 DECEMBER 2021
The Trustees conduct an annual revi￿ of alt tw of risk by whith the S¢xiety may be affected. HaviTrg
reviewed these risks, the Trustees are sa115fied that apprcfjriate systems are in place lo mana9e exposure ta
major risks. The Society holds Trustee lialx.lty insurance.
Govemance
The Tfuslees of ISPAD are committed lo the Sociws mission aThJ have ioined it5 board because they want lo
help the charity most effectivety carry out rts mission for the benefft of patients and familie5 Wrth diabetes.
Trustees fully recognise that meeting their ¢haritYs stated public benefrt is an ongoing requirement, understand
their roles and legal respon5ibilrties, and are committed to good govemance. and wish to contribute to ISPAD's
eonlinued inwrovement.
The board acts with integrty. adoptiryJ values and creating a culture that helps xhieve the organisalion's
charitable purposes. The l)oard is aware of the Knportance of the public's conf*Jence and twst in charities, and
Iruslees undertake their duties accordingty.
Trustees have the ulkn'mate fKluciary responsibilty for managing ISPAD'S funds and assets, protecting ts
reputation. and maintaining the respect of benefuaries, other stakeholders and the public by behaving with
integrity al all times. even when drfficult or unpopular de¢L%￿nS we ￿quIred.
The board leads the organisation in being transparent and accountab￿. The charity is open in ils work, unless
the￿ is good reason for il nol lo be. The Publ￿,$ trust that a charity is delivering a publi¢ benefrt is fundamental
lo ils ieputalion success. Making accountabilty real, Ihrovgh genuine and open tWCtrWay communication that
celebTales suc¢esses and demonstrates wllingness lo frcm mistskes. helps to build this trust and
confidence and earn legrtimacy.
OUR VISION, MISSION. AND VALUES
Our Vision
A better wortd for chiklren. adolescents and young ad￿￿ vmh diabetes.
Migsion Statement
To bring together professkjnals from va￿uS disciplines wrth an interest in clinical care, seienee. education and
advoc￿Y to prevent. treat or cure al fonns of diabetes ￿ youth.
By promoling ne￿Orking arKJ collaboration. our aim5 are..
To ensure appropriate treatment is available. indudng medKation. sew-monitoring equipment and
supplies,.
To increase awareness of all lypes of diabeles and prevent delayed dragnosis".
To reduce the morbidity and mortalrty caused by acute and chronic corry)lulNJns".
To ensure provision of education to youth, families and other caregivers..
To promote education of diabetes healthcaie teams workywide.,
To foster diabetes ￿search." and
To prepare and ¢Jisseminale dinical practice guideline5 and standards.
Our Values
Excellence
In care, based on rigorous and ethical research with ￿SPect for the Ind￿￿￿al child. alolescent and family and by
creating, evaluating and disseminating dobetes kn¢ywledge.
Collaboratlon
The s￿Iety cdlab¢yales with national and international paI￿nt and profrssional organisalions. healthcare
providers, policy makers and companh?s that make prfylucts or Pro￿de seNces for children wrth diabetes.
Page4

THE INTERNATIONAL SOCIETY FOR PECMATRIC AND ADOLESCENT DIABETES
IA Company Limited by Guarantsel
TRUSTEES. REPORT {CONTINUEDI
FOR THE PERIOD ENDED 31 DECEMBER 2021
Advocacy
For children and Caregivers lo improve awareness that diabetes is dsfferent foT children compared lo adults". to
end discrimination based on a child's diabetes.. and lo obtain increased funding for diabetes treatment. research
and prevention.
To promote the care of children and adrJescent$ with all fomis of diabetes mellrtus."
To be an advocate for children and adolescents with all foms of diabetes mellrtus." and
To enCou￿ge and support basic, clinical. ephdemiological, heatth. economic and all other relevant
research conceming pediatric and addescent diabetes mellrtus.
Public Benefit
Please see beh)w a summary of the piincipal aEIMbes arKI accomplishmen15 for the year which ISPAD ha5
carried out for the public benefit
In the furtherance of these objectives. the ISPAD Trustees have complied wrth the duty ￿ Section 17 of the
Charities Act 2011 to have due regard to the Charrty C￿nMIssIon,S published general and releV￿t sub-sector
guidance conceming the operation of the PLtblic Benefft reqU1￿ment under that Act.
PRINCIPAL ACTIVITIES AND ACCOMPUSHMENTS
Education
The extensive Clinical PraCt￿e Guidelines, p￿lIshed in 2018. ¢ontinue lo be promulgated and made available
on the Societys website and published in pediatr￿ Diabetes. the Society's joumal. The Clinical Pradice
Guidelines are an up404ate reference for all those con¢emed wTrth the management of childhood diabetes
v￿rldwIde. An extenswe upd*e and revision of the Clinul Pra¢b'ce Recommendations will be published in
October 2022.The Guidelines are developed and wrrtlen by membets of the ScKiety. led by an edrtorial team. In
addrtion. an external proje¢l officer has been appointed to take a lead in supporting the edrtorial team lo ensure
the guidelines meet inlernatNinal standards for dinical guidelines ensure harmonisalion of
recOmmendat￿ns. content, Language and evidence grading across chaplers.
The Guidelines are evidenc&based and are written using a review prccess involving input from the entire
membership. led by our excellent and enthusiaslrc volunteer editorial learn. A copy of ea¢h chapter is available
for download by anyone Inol ortty for the members) al no cost from our websrte www.ispad.org. Tran51alions into
other languages a￿ encouraged wrth no charge from ISPAD who coordinates these efforts lo avoid redundant
translations.
In 2020 and 2021. due to the pandemic. ISPAD had to postpone or translafe many of its ath"vth"e$ in a virtual
formal. Virtual educational acttvities included quarterty webinars. Virtual Science Schools for Physicians and
Healthcare Profes￿onal5, a5 weu as Poslgraduale Courses.
Advocaey
ISPAD collabofatgs closety wilh 'Lrfe for a Chikl. and 'Changing Diabetes in Children, two major programs whose
aim is lo improve access lo essentkn￿ drabetes medicTnes (insulin) and supplies for chiklren in the developing
world.
ISPAD continues to work Y￿h European Unron partners to rfflprove the qualrty of care throughout the world.
Science
The Annual Conferences invofve presentation of research activrties, state4)f-thevart lectures and topic specific
symposia. In 2020 and 2021, ISPAO'S Annual Conference took place virtualty over a three-day meeting in
October 2020 and 2021 wilh 1,285 and 1.414 Part￿pants respeclivety.
Page 5

TrIE INTERNATIONAL SOCIETY FOR PEDIATRIC AND ADOLESCENT DIABETES
IA Company Limited by Guarantee}
TRUSTEES. REPORT ICONnNUED)
FOR THE PERIOD ENDEO 31 DECEMBER 2021
ISPAD organises and runs. with volunteer experts. an annual research￿rien1ed Scienc* School for Physicians
{held virtualty in May 20211, as wdl as a Science Sch¢￿1 for Allied Healthcare Professionals working in diabetes
(held wrtualty in October 20211.
Applieations a￿ eixnpelrtNe for both sthools each year.
Visiting Feliowships allow young physicians and hea￿hCafe professionals to study research techniques and
prepare them to sel up research, either in collaboratKffi with the cenlre in wh￿h they study, or to initiate research
in a similar area In a more independent manner by provKling handsthon experience in an established Centre of
Excellence of research in the domain of interest. ApPI￿ntS present a research proposal for their study as well
as references. with letters of support from their hospital or universty arml from the head ol the research centre to
which they are appI￿n9 Idirecte<l by an ISPAD member) attesting lo the applicanl's acceptance al the centre lo
pursue the research project as presented. The accepting ISPAD member volunteers their time and centre
resources for the project. The lunds allryw the ￿1p￿nI to Iravel lo the cenlre and provide support for
accommodalion. Since 2017 ISPAD collab¢vates ￿ the Juvenik Diabetes Research Foundation IJDRFI and
awards 4 research fellowship. 25.000 dollars exh, and as of the calendai yeai 2019. 10 Alan Drash fellowships,
of 7,500 ddlars each.
The appltcalions are rewewed by the Trustees and Ihe Advtsory Crxnmittee who rank them on the qualty of the
application and potential beneffts lo the applicant. The suecessful fecipient provides ISPAO with a feport on the
project and is encouraged to submit an abstract to the annual meeting or a paper to the ISPAO journal.
Grants from G•neTal Funds
Travel grants are for young physi¢ian$ and healthca￿ professionals whose abstract$ have been accepted for
presentation at the Annual Confe￿nce. Due lo the pandemic. the "Travel Grants. We￿ replaced by °Support
Grants" for the Annual Conferences 2020 and 2021. These grants covered the costs ofthe registrat￿n fee.
The abslra¢l quality Iscoring as pei revwing pr¢xess by the Abstrxl Committee) as well as the ¢ountry of
residence and profession were part of the sele¢tw criteria for allctsting these grants. Applications Irom Lower
Income Counlr*s {as per Wodd Bank classification) and All*d Heathcaie Professionals were eyplicilly
encouraged.
ISPAD arranged the first virtual edition of the sc￿nce Schfxjl for Healthca￿ Professionals for a 24ay course
designed for fifteen healthca￿ professionals in the fiekl of chiklhotsj diabetes to learn aboul research
development. statistics and grant wrilin9.
Grants Supported by Funds from Reslricted Grants
Grants are obtained for the Science School for Phy5ich?ns for a 54ay course foi approximately twenty young
physician scientists lo learn how lo design a research study, appty proper statistics and wrrte grants. These
grants were provided in 2021 by Iwo comp￿￿5.
Volunteers
Members of the Society partiupate in all aspects ofthe knety e.g.:
serving on the Adwsory Council
serving as convener and organising wnmrttee mmbers forthe Annual COnferer￿e
serving on the ScientifK Committee
reviewing abstracts for the Annual Conference
acting as faculty lor the Science Schools and post graduate cou(ses
serving on writing commrttees for the Clinical Practice Guidelines
advocating for children wilh diabetes at k¢al. regiMal and intemational ￿ve15
workin9 with sponsors to increase contributions
attending the Annual Conference (primary fund-raising evenl)
serving as PTeceplor5 for Visiting Fellows
providing leadership in diabetes care for chddren and adolwents localty.
Page 6

THE INTERNATIONAL SOCIETY FOR PEDIATrIC AND At)OLESCENT DIABETES
IA Company Limited by Guarantee
TRUSTEES. REPORT ICONTINUEDI
FOR THE PERIOD ENDED 31 DECEMBER 2021
Members
The IntematKJnal Society for Pediatric and Adc4escent Diabetes has members from more than 100 countries. A
membership directory can be found on the ISPAD website 11￿￿1_1$pad.0rgl.
FINANCIAL REVIEW ANO RESULTS FOR THE PERIOD
Financial Review
The Current period is for the 18 monthyrKx4 ended 31 December 2021 1.2021,). The prior period is for the year
ended 30 June 20201'2020'1.
During the financial peric¥J 1 Juty 2020 to 31 December 2021. exper￿ltUre lolalled £552.306 12020.. £606,696)
and income was £819.264 {2020: £635.1541.
Our financ￿1 goals are to mwntain 5uffiuent funds hekl in reserve lo assure Ouf Continued existence under
difficult financial situations (poor income years, and unusual economic ts"mes}. while we continue to support
funding for Science Sch¢)ols, P.ost Graduate Courses, the Allan Drash ClinKal Fellowship, Researeh Fellowship.
Travel Grants. Pedialric Diabetes, Memberships, and specwl inrtialNes.
One of the challenges of hokling our Annual Conferences in drflerent ktations around the worfd is the wdely
Va￿ng costs and benefrts from Ihem. The 2018 Conference in Hyderabad, India was a successful Conference in
raising awareness across the Trmder region. bul resulted in a negative balance. while the 45th Annual Conference
in Boston. USA in 2019 resutted in a posrtive balance. The Annual Conferences in 2020 arKI 2021 were both
virtual, with good attendance as Ment￿￿d and they resulled in positive baL￿CeS.
A Crucial element of our charitable aims is to facilitate access to science and education, especialty for young
heahh professionals invofve<l wth diabetes. To this end we support travel grants (scaled according to
geographical localionl and specral travel gonts {fiJll payment of travel, registration and accommodation for
membefs from the developing world). Starting from Juty 1. 2020. ISPAD has reduced membership and
regi51ralion fees for members from Upper-mhldle4ncome countries as well as waived membership fees for Low-
income countries.
The COVID-19 pandemic has defin￿"¥ety affected the finance5 of ISPAD in the pTevious years and will continue
to do so also In the year5 to come (see below). We ￿e therefore, since February 2020. worked hard lo infom
members and corporate memberslsponsor5 about the new srtuations we are facing. In order lo maintain our
activities, ISPAD must in the coming years focus on keeping eosts drmn. as we expeel that income will likely be
reduced. This is both because we, like other SocÈties, expect a reduction in sponsored income as well as
reduced conference income due to reduced number of attendees as well as huher eonference inplemenlalion
costs le.g. venue rental costs. speaker ttavel expenses).
Reserve5 Policy
Our policy is lo maintain ￿serveS of sufficient furKls lo provKle orooing support for at least Or￿ year of ChaTIIy
activty. The balance of total rese￿eS at the year end was £1,152.869 12020. £885.9111 of which £1,067,861
12020." £843,665) was free reserves. this c¢)mpares witti £817,652 of total income in the period ended 31
December 2021, and £85,00812020.. £42,246) was restl￿ted. confe￿nce income is very unpredictable and the
CLITrenl finanaal climate demands that we hokl a sluhtly increased reserve. This is considered to be prudent also
in light of the fact that ￿rpOrate sponsorship has become rnore challenging to oblain.
Investrnent Pollcy and Objectives
The overriding philosophy and polry is lh* the Charity will take only mininal risk in order to preserve funds. The
objectives are lo gamer when possible, reasonable interest on held funds without placing reserves or day-to4ay
funds al risk.
Page 7

THE INTERNATIONAL SOCIETY FOR PEDIATRIC AND ADOLESCENT DIABETES
IA Company Limited by Guarantee)
TRUSTEES, REPORT ICONTINUEDI
FOR THE PERIOD ENDED 31 DECEMBER 2021
Key rlsks and uncertainties
As all charities, ISPAD has been facing increased risks and uncertainties due lo the COVID-19 pandemic. Even
though the pandemic cy￿entty has slowed down, we still expect Changes and new challenges due to changes in
ie. willingnes$ lo Iravd, being pawng members of the So¢*ty and sponsoring the Socth. This Eeads to
continuous drflicutties regarding both predthd income as well as expenses.
Income..
During the P￿¢JeMic. the lotsl number of members for the ffirst time in several years decreased. Al ISPAD. we
have experienced a stable increase in total membership numbers over a long Per￿d. In 2020-2021, we
experienced a decTease of approximalety 20%. Thi$ was mainty due to the needed repeated wrtual ISPAD
Conference 2021, as in 2020. Even though the virtual Conferences were well attended. we missed the effects we
usually ObSe￿e localty. In 2019-2020 we gained a sKJnrficanl amount of new members from North America due
to ISPAD 2019 in B051on, while we had a Iremendous increase n members from Ind￿ and neighbouring
countries due to our conference in Hyderabad in 2018. The obvious reason for this local effect is a reduced
conference fee for pawng members. This effed was complelety missing for ISPAD Virtual Conference 2020 and
2021. We are working hard lo maintain our total number of members, and hope that ISPAD 2022 on site in Abu
Dhabi wim increase the numbers of members. both in the Region as well as Wo￿aw￿de.
Regarding Corporate Membership and Sponsorship. Wfft￿h are extremety important sources of income for
ISPAD. the situation is still uncertain. So far. all key sponsors have maintained Iheir commitments. Still, we are
aware th* the situation for many of our Corporate collaborators are uncert•'n, and we should not lake their
5UPPOrt for granted for the upcoming years.
The conference income for the fiscal year 2021 was as expected. due to the high lever of sponsorship income
and lower expenses than wrth an in-person event. Regarding the on-stte Conference in Abu Dhabi 2022, we
expect a negative balan￿. This is both because of en expected k)w number of attendees and redueed
sponsorship income. Still this is in line wrth the overall aim of ISPAD (as previously described). and the event is
thought to raise knowledge and awareness of diabetes in a reg￿n of the world that up to dale never has hosted
an Annual ISPAD Conference. TherefcKe. this expected neg*ive balance has been included in the budget, and
will not ￿p￿sent a maJoT ehallenge for the o¥ernll financ￿1 stiualion of the s￿￿ety.
enses..
There are still uncertainties with respects to the alllxation and ftymat of several of ISPAD core aclmties. This
includes our science schoo15, both for physicians and healthca￿ providers. the ASPED4SPAD-Lilly Academy.
CDIC training and finalty the Allan Dra5h fellchvships. The restricted funding from dtherent sponsors for these
adivrties wll depend on the activrties, tomal Iin-person or virtuat), wheTeby some might be postponed to a later
dale. These adNities a￿ of course very mnportanl for ISPAO as society. and we have to be flexible, dynamic and
pragmatic lo maintain as many as them as well as possible desprte Ihe pandemtc.
In summary. there are more risks and uncertainties than usual in the current situation. Nonetheles5, the financial
situation is very safe within the fiscal year 2021 due lo headroom given by the hNJh level ol reserves.
The Trustees undertook detailed plannirYJ and forecasting with dosety monitorir*J of the siluatson Sin￿ the
beginning of the COVIO-19 pandemic. Due to thi5. the Trustees believe that the ChariVs financial resources.
strong reserves position and contsngency planning is sufficient lo albw the Charity lo continue as a going
concem lor the foreseeab￿ future. being al ￿¥$1 12 months from the dale of approval of these financial
slatemenls. There are no material uncertainties about the abilty to contsnue and therefore the financial
statements have been prepared on a going con￿rn basis.
Looking ahead
ISPAD has increased eryagement vrfh p*￿nI adv¢Jcacy groups during this reporting year. has encouraged
them to meet al Oilf Annual Conferences and to publ￿•se the work and mission of ISPAD. ISPAD has played a
rn4or role in Commun￿allOn wrth the community about COVID-19 safe pradi¢es arKI effe¢ls on the dkabetes
Page 8

THE INTERNATIONAL SOCIETY FOR PEDIATRIC AND ADOLESCENT DIABETES
{A Company Limited by Guarantsg)
TRUSTEES. REPORT {CONTINUED)
FOR THE PERIOD ENDED 31 DECEMBER 2021
community during 2021. Our Annual coftferen￿ for 2022 wiu be on site in Abu Dhabi, with the opportunity lo
participale also wrtualty.
Mainly due to the COVID-19 pandemic, the financjal clwnate 1$ stili challenging and rules and regulations for
support from industry have changed making (( more diffKuli for ISPAD to reeetve corporate membership fees or
specific grants. We are gralefvl for those who have been able to conts.nue to support ISPAD. For thi5 reason,
ISPAD offers drflerenl levels to become a corporate member or sponsor. with drfferent benefits. ISPAD. to
enhance its relalKJnship with companies. organries a specffic and strategic meeting (Corporate Advisory Board
Meeting) annually with all wnpanies during its Winter Meeting in February. Since 2019, this meeting has been
tsking place adjacent to the A￿0 {Advanced Technologies and Treatments in Diabetes} in order lo enable
maximum industry attendance. The invoiced year for corporate membership is now the Calendar year (January
lo Deeemberl and hence the accounting will change. The accounting year was transth.oned from a July lo June
financral year to a calendar year by January 1. 2022. In order to adjust to the calendar year, the fi$¢al year th*
started on July 1, 2020 wos extended by 6 n￿nthS to end on December 31, 2021.
Membefship payments are becomin9 illcreasingty important. The number of lapsed members might be
significantly reduced by improving the payment process and the possibilities to interact wrth other members. In
order lo improve payment of ￿￿MbershIP fees and to overc¢yme some te¢hnKal issues, ISPAD has requested
K.l.T Group GmbH lo improve the. membership system and exlend on the overall experience to enrol membe
in ISPAD activities. Now, after 3 years from rts implementation the system appears to be working well and
membership had been sleadity increasing every year until COVID-19. We hope lo see an increase duwing 2022
because of the Annual Conference in Abu Dhabi. amhough this is drff¢cutt to predict wrth certainty.
We anticipate that ISPAO will likety face the late consequences of the COVID-19 pandemic in the Up￿ming
fiscal years. We expect that some corporate member5 and sponsors may wlhdraw a$ their financial situation is
uncertain. Allhough others may become new members. we may see a Teduclion In total corporate members and
sponsorships. The diffieukies in organising the Annual Conference on-srte may relum. if so we are unsure of how
Virtual Conferences will affect both the attendance to the ¢onferer4ce ((self and the total numbers of ISPAD
members. If we hopelulty are to arrange on-site actiwlies in the future as planned. expenses may likely increase
as a consequence of hwher inlemalional aldine expenses. Therefore. mainlaining reserves of sufficient funds
ale mole important Ihan ever for ISPAD.
We have also inrtiated a ￿￿Sed accounting system for invoicing to be perfomied by K.l.T. Group in conjunction
with and approval by the ISPAD Treasurer. This system is designed to prowde redundancy and avoid missing
¢)pportunities for ISPAD funding.
Charlty Govemanee Code
ISPAD
aims
lo
address
the seven
https.'II￿￿.Ch3ntyg0¥ernanCeCO￿e.Ofy1enIfronI-p3Ye
principles
Charity Govemance Code
Oiganisational purpose." to facilrtale the missth of ISPAD to Nnprove the lives of children, adolescents and
young adults with diabetes wod(IMde. To do thrs we provide forums. both Wr￿en (guidelines, e-Learningl
and fa¢e-tO-face (Sc￿nIff￿ meetings, science schools for phyS￿lan$ and for allied healthcare
professionals, and poslgraduale courses). lo physi￿an5 and heatthcare professionals who provide care
for young people Nwth diabetes. We have three main pillars lo aCh￿ve our mission.. scien￿. education and
advocacy.
Leadership,. the TnJstees comprise an Execulrve Board and are advtsed by an Advisory Committee. We
take collective responsibih'ty for the Board's decisions. The roles of each Trustee are clearly idenb"f
(Winter Executive Meeting February 20201. Since 2017, the Executive Board now includes a
Communicat￿n$ Director to facilitate effeclNe ccffiMunicat￿n with the membership and communty.
Integrity.. the Executive Board acts with integrrty and is conscious of how it is perceNed by the membership
and the public. A corporate liai50n officer was appointed in February 2018 to assist with communication
and perception in the community. the"Oiabetes Online Communw including con5umer"bloggers". We
faeililate their meetings al our Annual Conference and meet with them at meetings organized by the
Pa9e 9

THE INTERNATIONAL SOCIETY FOR PEDIATRIC AND ADOLESCENT DIABETES
IA Company Limited by Guarantsel
TRUSTEES. REPORT {CONTINUEDI
FOR THE PERIOD ENDED 31 DECEMBER 2021
consumer organizalion Chiklren Wrth Diabetes (February 20201. Confiicls of interest are decla￿d.
Decision-making, risk and control.. the Board makes sure that operational plans and budgets are in line
with the charity's purpose. The Board invested in foNard planning by expenses for represenlalives lo
meet and teach in India1201&20201. the country with the second largest number of thildren wrth
diabetes. and in Africa12019. 20201
Boaid effectiveness". the Boacd ads as an 8ffectNe team and ¢n￿Urag8S Members of the Advisory Board
to set up Sp￿la1 Inte￿$1 Groups al the Annual Conference in October 2017 onwards. Trustees are
iefleclive of their perfomiance and discuss areas that can be strengthened.
Equality, Diversty and Incluston.. the Board encourages diversty in the mernbership of committees. and in
special non-physiuan positions on the Adwsory Board.
Openness and accountsbility," the Board comlnunicates with the membership by the Annual General
Meeting and by monthly newsletters sent by email. The Preshlenl writes special messages since 2017
which can be sourced on the SO¢￿￿$ websrte. The Annual Report is circulated lo the Membership and is
available to the Public.
Statement of Trustees. Responsibil•ties
The Trustees Iwho are also directors of the Interna￿ana1 S￿ietY for Pediatn"c and Add8￿ent Diabetes for the
purposes of company lawl are responsible for preparing the Trustees, Annual Report and the financial
siatements in accoidance %wth appltsble law and United Kingd(*n Generalty Atcepled Accounting Practice
(United KirvJdom Aeeounting Standards).
Company law requires the Trustees to prepare financol statements for each financial year. Under company law
the Trustees must not approve the financial ststements Un￿8$ they are satisfied that they give 8 true and fair
view of the slate of affairs of the Charrtable Company and of the incoming resource5 and application of
resource5, including the income and expenditure, of the Charrtable Company for that p8ricwJ. In preparing these
financial slalements, the Trustees are required to-.
gelecl suitable accounting polic￿5 and then apply them consistentty."
observe the melhc#Js and principles in the Chanties SORP.,
make judgments and estimates Ihal are reasonable and prudent.,
state whether applicable UK accounting standards have been follwed, subpct to any material departures
disclosed and explained In the finanual staternenls',and
prepare the financial slalements on the goiry COn￿M basis unle55 it is inappropriate to presume that the
Charrtable Company will continue in business.
The Twslees are ￿sponSible for keeping adequate accounting records Ihal are sufficient lo shcpw and explain
the Charitable Company's transactions, disclose w¢th reasonable accuracy at any lime the financial position of
the Chantable Company and enable them to ensure thal the finanaal statements compty wrth the Companies Act
2K6 and the provisions of the Chantys constrtution. They are also responsible for safeguarding the assets of
the Charity and her￿ for taking reasonable steps for the prevention arKI detection of fraud and other
irregularities.
The report of the Trustees has been prepa￿ in accordance with the special pwsions relating to small
companies subjecl lo the small ecrfnpan￿ fegime within part 15 of the Companies Act 2006.
Approved by the Board of Trustees of The Internat￿nal Society for Pedialric aThJ Adolescent Dtheles on
and signed on its behaw by".
Df Lars Krogvold
Trustee
8 November 2022
Page 10

THE INTERNATIONAL SOCIEry FOR PEDIATRIC AND ADOLESCENT DIABETES
IA Company Limited by Guarantee)
INDEPENDENT EXAMINER'S REPORT
FOR THE PERIOD ENDED 31 OECEMBER 2021
Independent Examlnerfs Report lo the Trustees of The International Society for Pediatrfc and
Adolescent Diabetes I'the Charity,)
I report lo the charity Truslees on my examination of the accounts of the Charity for the perKKI ended 31
December 2021 which are set out pages 13 to 32.
This report is made 501ely to the charrtab￿ compan¥s trustees. as a b(*, in accordance wrth Chapter 3 of Part
16 of the Companie5 Aet 2006 and the Charitab￿ companys trustees as a body in accordance with section 154
ol the Charities Ad 2011. My independent examinerfs work has been undertaken so that I might state to the
charitable compan￿5 Iruslees those matter5 1 am required to state lo them in an independent examiner's report
and for no olhef purpose. To the fUl￿t extent perrnrtted by law. I do not accept or assume responsibility to
anyone other than the charitable company. the Charitab￿ companys members as a body and the charitable
companys trustees as a b￿JY for my indeper¥Jenl examinerfs work. for this report. or for the opinions I have
formed.
Responsibilities and Basi5 of Report
As the Trustee5 of the Chanty land its directors for the purposes of company lawl you are responsible for the
preparatson of the accounts in accordance the requirements of the Companies Ad 2006 {Ihe 20C6 Acl'l.
Having satisfied myself that the accounts of the Charity are not required to be audrted under Part 16 of the 2006
Act and are eligible for independent examination. I report in respect of my examinalTron of the Charitys accounts
car￿d out under section 145 of the Chafities Act 2011 (Ihe 2011 Act'l. In carrying out my examination I have
followed the Directions given by the Charity Crynrrission under section 145151{bl of the 2011 Act.
Independent ExamineV5 Statement
Since the Charity's gross income exceeded £250.000 your examiner must be a member of a l)ody listed in
section 145 of the 2011 Acl_ l confirm that l am qualffied to undertake the examination because l am a member
of The Association of Chartefed Certified Accountants. which 15 one of the lisled bodies.
I have completed my examination. I confirn that rKJ matters have come to my attention in connection with the
examinalhjn givrng me cause lo beI￿ve..
accounting records We￿ nol kept in respect of the Charity as required by secbon 386 of the 2006 Act. or
the accounts do not accord wrth those records", or
the accounts do not compty ¥￿h the accounting requirements of sectitin 396 of the 2006 Act other than
any requirement that the accounts give a Yrue and fairf wew wh￿h is not a matter Conside￿ as part of
an independenl examination", or
the acc¢)unls have not been prepared in aceothrte vrith the methods and princip￿$ of the Slalemenl of
Rec(xnmended Practice for accounting and reporting by charities {applicable to charrties preparing their
accounts in accordance with the Financial Repo￿.n9 Standard applicable in the UK and Republic of
Ireland IFRS 10211.
I have concerns and have ¢c*me ￿ro$S no other matters in connection with the examination to which
attention should be drawn in thi5 report in order lo enable a proper understanding of the accounts to be reached.
Page 11

THE INTERNATIONAL SOCIETY FOR PEDIATRIC AND ADOLESCENT DIABETES
{A Company Lwnited by Guaranteel
INDEPENDENT EXAMINER'S REPORT (CONTINUED)
FOR THE PERIOD ENDED 31 DECEMBER 2021
Signed..
Dated: 09 December 2022
Tara Westcott FCCA Crowe U.K. LLP
Fourth Floor
Sl James House
St James Square
Chellenham
GL50 3PR
Page 12

THE INTERNATIONAL SOCIETY FOR PEOIATRIC AND ADOLESCENT DIABETES
IA Company Limlted by Guarantee)
STATEMENT OF FINANCIAL ACTIVITIES IINCORPORATING INCOME AND EXPENDITURE ACCOUNT}
FOR THE PERIOD ENDED 31 DECEMBER 2021
Unrestricted Restricted
Total
funds
funds
funds
Total
18 months to 18 months to 18 months to
funds
31 December 31 December 31 December
12 monlhs lo
2021
2021
2021 3Q June 2020
Note
Income fvom:
Donations
Charitable activities..
Membership income
Coporate sponsorship inujme
Corporate membership
JDRF Fellowship
Conference income
Olher charrtable adivrtie5
Invèslmenls
Other income.. Royalties
400
400
3.469
138.324
138.324
138,841
209.489
94.936
225,738
1,612
135.292
161.960
150.227
80,631
68,522
138,841
209.489
94.936
225.738
1.612
870
34.183
9.924
9.924
Total income
583.875
819.264
635, 154
Expenditure on:
Charrtable actiwties
359.679
192.627
SS2,306
606,696
Total expondiluFe
359,679
192.627
552.306
606,696
Net movement In funds
Rè¢oncillation of funds-
Total funds brought forward
Net movement in fvnds
224.196
42.762
266,958
28,458
843.665
224.196
42.246
42.762
885,911
266.958
857,453
28.458
Total funds ca￿led for￿rd
1.067,861
1,152.869
885,911
The notes on pages 16 to 32 fcffii part of these financial statements.
Page 13

THE INTERNATIONAL SOCIETY FOR PEDIATRIC AND ADOLESCENT DIABETES
{A Company Limited by Guarantee}
REGISTERED NUMBER: 06641016
BALANCE SHEET
AS AT 31 DECEAIBER 2021
31
De￿mber
2021
30 June
2020
Note
Current assets
Debtors
Cash at bank and in hand
203,178
1.416A07
57.328
1,182,377
1.619,585
1.239.705
Credi(ors". amounts falling due wrthin one
year
12
(456.448)
(320.364)
Net current ass•ts
1.163,137
919,341
Totsl assets less ¢urTent liabilities
1.163.137
919,341
Credrtors." amounts falling due after more
than one year
13
110.268
133.430)
Total net assets
1,152,869
885.911
Charity funds
Restricted funds
Unreslr¢cled funds
14
85.OD8
1,067.861
42,246
843.665
14
Total funds
1,152,869
885.911
The Charity was entitled lo exemption from audit under section 477 of the Corry)anies Ad 2006.
The membef$ have not required the company to r)btain an audit lor the pertsj in question in accordance wrth
seCt￿n 476 of Compan*s Act 2006.
The Tnjslees adtnowled9e Ihwr responsibilit￿ for ccvnplwThJ with the requirements of the Act with respect lo
accounting recofds and prepar*ion of finanoal st*emenls. The financial statements have been prepared in
accordance wth the provisions appluble to entities subj'ect to the small companie5 regime.
The financial ststements were apwoved and authonsed for issue by the Trustees on
and signed on theii behalf by".
Dr Lars Krogvokl
Trustee
8 November 2022
The notes on pages 16 to 32 fom part of these financial statements.
Page 14

THE INTERNATIONAL SOCIETY FOR PEDIATRIC AND ADOLESCENT DIABETES
(A Company Limited by Guarantee)
STATEMENT OF CASH FLOWS
FOR THE PERIOD ENDED 31 DECEMBER 2021
31
D•cember
2021
30 June
2020
Note
Cash flows from operntlng activities
Net cash fr¢Jm operating activiti.es
16
234.030
65, 166
Cash flows from investing activities
Interest recwved
870
Net cash provlded by Investing aetivitles
870
Change in cash and cash equlyalents in Ihe perlod
Cash and cash equivalents at the beginning of the perK)d
234.030
66.036
1,182,377
1, 116,341
Cash and cash equlvalents at the end of the period
17
1.416.407
1. 182,3T7
The N)tes on pages 16 to 32 fomi part of these financial statements
Page 15

THE INTERNATIONAL SOCIETr FOR PEDIATRIC AND ADOLESCENT DIABETES
(A Company Limit•d by Guarantee)
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 DECEMBER 2021
General Infofmatlon
The Inlemalional Swiety for pedIatr￿ and Adolescent Diabetes {ISPAD) is a tharitable company, limited
by guarantee. Iregistralion number 06641016 England & Wales) and the Charity Commission (charity
number 1126927). The registered office address is Harrison Clark Riekerbys Limited, Ellenborough
House. Wellington Streel. Cheltenham. Glouceslershire. GL50 1YD.
Accounting policies
2.1 8asis of preparation of financial statements
These financial stslements present informats.on about the Charity as an individual undertaking. The
current pef￿ 15 for the 18 monlh-perK*J ended 31 December 2021 {'2021'}. The prior period is for
the year ended 30 June 20201.2020.).
The financial ststemenls have been prepared in accordanee with the Charities SORP IFRS 102) -
Accounting and Reporting by Chariti"es". Statement of Recommended Practice applicable to charities
preparing their accounts in accordance wth the Finanaal Reporting Standard applicable in the UK
and Republic of Ireland IFRS 1021 (effective 1 January 20151, the Financial Reporting Standard
applicable in the UK and Republic of Irelarml {FRS 1021. the Companies Act 20CE and the Charities
Act2011.
The Intemalional S¢x*ty for Pe¢jIatr￿ and Adolescent Diabetes meets the definrtion of a public
benefit entty under FRS 102. Assets and l1abilrt￿S are initialty ￿COgnised at historical cost or
transaction value unless othe￿iSe stated in the relevant accounting policy.
2.2 Going'concern
The Truslees have undertaken detailed planning and forecasting and continue to closely monitor the
long-term financial impact of Cov1￿19 a5 well as the developing global financial situation. As
described in the Trustees. Report membership income has been impacted and there are
uncertaint￿$ over fvture corporate inco￿￿ and income and costs associated with conferences,
fellowships and events.
Despite the tu￿nt circumstances the Trustees bel*ve that the Chartty's finanehql resources. strong
reserves position and contingency planning is sufficient to allow the Charity lo continue as a 90ing
concem for the foreseeable fLrture. being al least 12 months from the dale of approval of these
financial statements. There are no material uncertainties about the abilty lo continue and therefore
the financial slatements have been prepare<l on a gohng concem basis.
13 Income
Income is recognised in the financial statements when the Charity has enlrtlemenl to the funds, it is
probable that the income wll be received and the at7v)unt can be measured reh'abty.
Membership incoff* is r￿09￿1$ed in line with the f￿￿la1 year. Membership income for future year$
is defefred.
Page 16

THE Ii¥fERNATIONAL SOCIEry FOR PEDIATRIC AND ADOLESCENT DIABETES
IA Company Limited by Guarantee)
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 DECEMBER 2021
Accountlng pollcies Iconllnuedl
2.4 Expenditure
l eypendrture 1$ accounted for on an accruals basis. Supp)rt costs are apportioned to eost aclNrties
based on the estimated amoLtnl attributsble to that cost in the year on the basis of the estimated lime
spent on that activty. The irrecoverable element of VAT is included with the item of expense to which
it relates.
Charitable ath"vrties comprise all expeThJiture In￿rre{l dir8Ctty relating to the obj'eds ol the Charty.
Grants are recogni5ed when a constru¢tNe obligation arise5 that ￿5￿11$ ¥i the payment being
Unavo￿ab1e.
Govemance costs indude the costs connected with the Chartys eonstitutional and slalutory
requirements.
Charitable acts'vities are costs In￿￿e¢j on the companls ¢)perations, inclLKling SUPPOrt costs
costs relating to the govemance of the company apportK>ned lo charitable activrties.
2.5 Foreign currencies
Monetary assets and IHbilrttes den¢)minated in fooign currencies are translated into sterling al rates
of exchange ruling at the reporting date_
Transactions in foreign currenaes are translated into steding at the rate ruling on the dale of the
transaction.
Exchange gains and losses are recognised in the Slalement of Financial Aclrvitses.
The functional currencies of ISPAD S￿ eonsK4ered to be Euros and US Ddlars because these are
the curreneies used by the members of the S¢xiety in the primary economic environment in which the
charity operate5, Eurcye and the rest of the workl. The financial statements are presented in pound5
sterling.
2.6 Taxation
As a registered Charrty the entrty is eolrtknl lo taxats.on exempts.ons on all f(s income and gain5,
properfy apPl￿d for rts charitable purposes.
2.7 Debtors
Trade and other debtors are re￿nISed * the settle￿￿￿t amount after any trade discount offered.
Prepayments are valued at the amount prepaNJ.
2.8 Cash at bank and in hand
Cash is rep￿seAted by cash in hand and dep05ts wrth financial institutions.
2.9 Creditors
Creditors a￿ recognrsed orbce there is a kgal or con$truotNe obligation that commits the Charty lo
the obligalpJn.
Page 17

THE INTERNATIONAL SOCIEfY FQR PEOIATRIC AND ADOLESCENT DIABETES
(A Company Limited ty Guarantee)
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 310ECEMBER 2021
Accounting policies (conlinued)
2.10 Financial instruments
The Charty onty has financol assets and finanoal liabilibes of a kind Ihat qualify as basic financial
instruments. Bas￿ financial instrument5 are In￿"alty recoJnised al transaction value and subsequently
measured at their settlement value.
Ill Fund accounting
Unrestricted funds expendable at the dwetion of the Trustee$ in fvrtherance of objectives and
administr*ion of the Charrty.
Resth"cted funds are to be used for SPecrf￿d purposes Jaid dcwn by the donor. Expenditure for those
purposes 15 charged to the restrKted fuThJ.
Ciitlcal accourting estimates and areas of judgement
Preparation of the financial statements reouiTe5 management to make any signffjtsnl estimates and
judgements where necessary. The items in the financial statements where material esbmales and
judgements have been made indude-
Impairment of d•blors
The charity makes an estimate of the recoverable value of membership debtcrfs. When assessing
impaim*nt management considers hi5ton¢al exper*nce. See note 11 for the nel Carr￿n9 amount of
debtors.
Investment income
Unrestricted
Total
funds
ftsnds
18 months 18 months
to31
to31
December December
2021
2021
Bank interest
un￿Stricted
Total
funds
funds
12 months to 12 months lo
30 June
30 Jun
2020
2020
Bank interest
870
870
Page 18

THE INTERNAnoNAL SOCIETY FOR PEDIATRIC AND ADOLESCENT DIABETES
IA Company Limited by Guaran¢ee}
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 DECEMBER 2021
Anatysi5 of èxpenditurè on charitable a¢livities
Summary by fund type
Unrestrl¢ted Restrlcted
Total
fund5
funds
funds
18 months
18 months 18 months
to31
to31
to31
DKember December
December
2021
2021
2021
￿￿berSh￿ costs
Conference eosls
Grants and Prizes (note 7)
ISPAD Science School for Physioans
ISPAD Science School for HeaJth¢are Profession*
PETCAJPETCWA Research and projec15
Alan Drash
Discovery of Insulin Ichiklren's B¢x)kl
Dexcom Guidelines
JDRF Fellowship
Other
172,874
44.187
19,451
24,148
8.127
1.182
22,149
172.874
44.187
28.902
21,543
8,127
1.182
88.737
1.612
2S.098
156,717
3,327
9,451
12.6051
66.S88
1,612
25.098
92,483
64.234
3.327
Total 2021
359.679
192,627
552,306
Page 19

THE INTERNATIONAL SOCIETY FOR PEDIATRIC AND ADOLESCENT OIA8ETES
(A Company Limiled by Guarantee}
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 DECEMBER 2021
Anatysis of expendlture on Charhable aclivities l¢ontinued)
Surnmary by fund type I￿ntInued)
UnTrstitled
ReslriGled
Tolal
funds
funds
funds
12 months lo 12 months to 12 miynths lo
30June
30 June
30 June
2020
2020
2020
Membership eosls
COnfereTh￿ costs
Grants and Prizes (note 7)
ISPAD Seience School for Physiaans
ISPAD Science Schod for Heahhcare Professionals
PETCA Research and pr(Jiects
Alan Drash
SWEET proje
E Learning
Changing Diabetes in Children Icwnbodia)
JDRF Fellowsh
109.062
23,036
54.527
11.021
19.838
24. 733
19.838
1, 102
2,204
109,062
22,036
74,273
49,005
67,633
24, 733
80.693
28,481
8,592
13.076
114,203
14,909
19,746
37,984
47,T95
60,855
27.3T9
6,388
10,872
81. 140
5.482
33.063
9.427
her
Total 2020
309.055
297,641
606.696
Page 20

THE INTERNATIONAL SOCIETY FOR PEDIATRIC AND ADOLESCENT DIABETES
IA Company Limited ty Guarantee)
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 DECEMBER 2021
Anatysis of expenditure by activities
Activities
undertaken
Support
directly
costs
18 months
18 months
to31
to31
Deumber December
2021
2021
T¢tal
funds
18 months
to31
Dgcember
2021
Membership Costs
conferen￿ costs
Grants and Prizes {nole 71
ISPAD Science School for phys￿an$
ISPAO Science School for Healthcare Profess*Jnals
PETCAIPETCWA Research and projects
Alan Drash
SWEET project
Changing Diabetes in Ch￿dreft {Cambod*l
JDRF Fellowshp
Other
172.874
33.225
3,322
4,429
4,429
172.874
44.187
28.902
21.543
8.127
1,182
88,737
1.612
25,098
156,717
10,962
25,580
17.114
3.698
1.182
22.149
1,612
25,098
92,483
64,234
- I'l
3,327
3,327
Total 2021
244.317
307.989
552,306
Page21

THE INTERNATIONAL SOCIETY FOR PEDIATrIC AND ADOLESCENT DIABETES
IA c￿npaThY Llmited by Guarantee)
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 DECEMBER 2021
Analysis of expenditur• by activities Icontinued)
ActiVit￿S
Support
Total
undertaken
costs
fvnds
direclly 12 months to 12 months to
12 months to
30 June
30 June
30 June 2020
2020
2020
Membership costs
Conference eosls
Grants and Prize5 (note 71
ISPAD ScEnce School for Physicians
ISPAD Science School for Healthcare ProfeSsY￿al$
PETCA Researth and projects
Alan Drash
SWEET project
E Learning
Changing 0￿beteS in Children (Cambod￿)
JDRF Fellowshp
Other
38.32T
11.015
52,231
37,984
47.795
23.631
60.855
2T.379
6.388
10.872
81, 140
70.735
11,027
22.042
11,021
19.838
1.102
19,838
1. 102
109.062
22.036
74,273
49.005
67.633
24. 733
80.693
28.481
8.592
13.OT6
114.203
14,909
33.063
Total 2020
408. 178
798.578
606.696
Page 22

THE INTERNATIONAL SOCIEfi FOR PEDIATRIC AND ADOLESCENT DIABETES
(A Company Limilgd by Guarantoe
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 DECEMBER 2021
Grants and priz•s
31
December
18 months
10 31 12 months to
December
30 June
2021
2020
30 June
ISPAD Prrze for Achievement
Special Travel Grants
Young Investigator Awar(I
ISPAD Prize for Innovation
Leslradet Award
Standard Tiavel Grants
Hero Award
Patient Advocates
2.374
1.868
1.164
2.470
2A15
13.257
1.028
1,004
5,069
22,968
3,274
6,035
5.368
9,412
105
25,$80
52,231
Details of the winners ol ISPAO prizes and felkxshp$ is awlable at:
www.ispad.orgDpage=ISPADPiizeWinnets.
All grants, prizes and lelThvships are to individuals.
Page 23

THE INTERNATIONAL SOCIETY FOR PEDIATRIC AND ADOLESCENT DIABETES
IA Company Limited by Guarantee)
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 DECEMBER 2021
Support costs
31
Ot¢ember
18 months
to 31 12 months to
December
30 June
2021
2020
30 June
Meeting expenses
Insurance
Bank Charges
Credrt Card fees
Management charge
Printing, postage and ststionery
Advertising and promotion
Goveman¢e costs
Independent Examinefs fees
Legal fees
Exchange lossl (gain)
Webinars
532
1.472
3.339
7.408
190.378
265
6.626
49.9T5
1,047
3,950
6,968
122, 139
530
16.361
12.640
2,246
74.490
8.595
13.631
555
(16,578J
307,989
198.578
Exchange rat• gainlloss
This is not a trading gain as ISPAD does not trade cu￿en¢1es. It ts an 'accounling adjyslmenv and
represents the drffe￿nee irb value of non-sterting balances al the year end in comparison to the start of
the year where diffe￿nI exchange rale5 were in effect. As an eXarnp￿ a balance of $10,000 at the start
of the financial year might be worth £7,600 {* a USDIGBP exchange rate of 0.761 and al the end of the
yeai that mi9ht have changed lo £7.870 {al a USDIGBP exchange rale of 0.7871. This woukj result in an
apparent gwn of £270 while in fa¢t there h•J been no change to the $10.000 held.
The fo￿l9n exchange Ioss 15 incI4￿ed in 5UPWt Costs and wa5 £74.49012020". £16.578 gain).
Page 24

THE INTERNATIONAL SOCIETY FOR PEDIATRIC AND ADOLESCENT DIABETES
{A Company Limited by Guarantee)
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 DECEMBER 2021
Indepondent examinerfs remunernlion
18 months
to 31 12 months to
D•cemb*r
30 June
2021
2020
Fees Payats￿ to the Ch8nWs independent eX￿Iner for the independent
exarninalion of the Chwty's annual accounts
Fee5 payable lo the Charitys independent examiner in respect of..
l assurance sefwces not included above
9,640
3.000
10.
Trustees. r•muneration and expenses
During the period. Tr) Tnjstees received any remunerathm or other beneffts (2020- £NIL).
During the period ended 31 December 2021. expenses totalling £532 were reimbur$ed or pa"Ml directly to
4 Trustees (2020- £11.488 to 5 Tnisteesj. Expen￿$ related to travel. a¢wnodation and subsistence.
11.
Debtors
31
De¢emb•r
2021
30 June
2020
Due within on• y•ar
Trade debtors
P￿paymentS and accwed income
197.868
5.310
49,839
7,489
203.178
57,328
Page 25

THE INTERNATIONAL SOCIETY FOR PEDIATRIC AND ADOLESCENT DIABETES
{A Company Limited by Guarantee)
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 DECEMBER 2021
12. Creditors: Amounts falling due within one year
31
December
2021
30 June
2020
Trade creditors
Accruals and deleffed income
190.907
265,541
105.049
215,315
456.448
320.364
31
December
2021
30 June
2020
Deferred income at 1 Juty 2020
Resources deferred during the perth
Amount5 Teleased from previous periods
158,227
261.708
11S8.227
125. 137
141.906
(708.816)
261.708
158,227
Deferred income rel*es to membership subscriptions, co￿Orate mernbership for future years and the
JDRF Feltuwship.
13. Creditors: Amounts fallin9 due after more than one year
31
Decernber
2021
30 June
2020
Accruals and tlefetted income
10.268
33,430
Page 26

THE INTERNATIONAL SOCIEry FOR PEDIATRIC AND ADOLESCENT DIABETES
IA C¢>mpany Limited by Guarantee)
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 DECEMBER 2021
14. Statement of funds
Statement of funds - Current perlod
Balance at
31
8alan¢e at
1 July 2020
D￿ember
2021
Income Expenditure
Unrestrlcted funds
General FurKls- all funds
843,665
583.875
1359.679) 1,067.861
Restrlcted funds
Alan Drash Fellowship
Innovation Prize
Wedcasting sponsorship
Young Investvjalorfs Award
Lestradet Award
Discovery of Insulin
ASPED-ISPAD Llly Diabetes p￿radUate
course
66.586
4.190
{66.5861
12,472}
11.928
3,254
13.646
3.254
6.877
10.174
2.095
7.542
1.612
{1.1641
{2.4151
{1.6121
5,047
8,809
8.809
2,453
34,816
3.911
1.068
JDRF Fellowship
Novo NordiskJLily SSP
Lily Prize for Achievement
Hero Award
ISPAD Guidelines 2022
94,936
24,949
6.285
2,096
25.098
192,483
2.605
12.374)
11.028)
12S.098
7.262
42.246
235.389
1192,6271
85,008
Total of funds
885.911
819.264
1552.3061
1,152,869
Page 27

THE INTERNATIONAL SOCIETY FOR PEDIATRIC AND ADOLESCENT DIABETES
IA Company Limiled by Guarantee)
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 DECEM8ER 2021
14. Staternent of fvnds Icontinuedl
Statemenl of fvnds- prior period
Balan￿ at
30 June
2020
8818nce at
l July 2019
Tr8nsfe
in/oul
Inc¢)me Expenditurg
Unrestricted fvnds
General Fur
5,277
392,563
(309.055)
f45. 120)
843,665
R￿trict¥d funds
ISPAO SSHP
Nairobi Education Prcyect
Alan Orash Fdl¢Mhip
Innovation Prize
Wedcasting sponsorship
Young Invesligalorfs Award
Lestradet Award
(4,927)
1.640
(130)
13,41Kl
3,254
4,925
5.361
6. 727
12.171
(47, 795)
(5,482)
(60,855)
(6.035)
40.551
3.842
130
.60,855
11.928
3,254
5.946
5.047
4,295
5.054
(3.274)
(5,368)
(6,388)
Discovery of Insulin
ASPED4SPAD Lilty Dtheles
Postgraduate course
Lily-SWEET Proied
JDRF Felkwship
Novo NordiskJLity SSP
LI￿ Prize for Achievemenl
ISPAD SSHP
(339)
27,379
80.631
36.673
(27.379)
{81, 14Q)
(37,984)
(5.069)
(10,812)
509
8.573
7.262
525
{98J
70.970
52.176
242,591
1297,641)
45, 120
42,246
Total ol funds
857.453
635, 154
(606.696)
885,911
Page 28

THE INTERNATIONAL SOCIETY FOR PEDIATRIC ANO ADOLESCEMT DIABETES
IA Company Limited by Guarantsel
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 DECEMBER 2021
15. Slatement of Funds {continuedl
ISPAD Seience S¢hool for Healthcare Professionals
This is funds used lo support the S￿ence School for Heamhcare Professionals which is a three day course
in the field of chiklhc*)d dthtes to aboul research development. statistics and grant wri(ing.
Nairobi Education Project
The Nairobi Edu¢alion ProiKI is a johnl venture btheen ISPAD and ESPE IThe European Society of
Paediatric Endo¢rinologyl to educate doctors from AfrKan countries in the management of endocrine
diseases Including diabetes. Groups of Fellows are resident in Nairobi foT 6 months al a lime during which
they receive tuition from visiting internats.onal expert$ who spend 24 week$ wth them.
Alan Drash Fellowship
Alan Orash was one of ISPAD'S founding membets arKI in his memory ISPAD offeTs a 6 week dinical
fellowship. Applications are invited frcffi member5 below 45 yeaT5 of age. A ￿port must be submrtled to
the ISPAD Steering CL¥nmittee wrthin l year after fellowshy.
The ISPAD Prize for Innovation in Pediatric Diabeles Care
Sponsored by NovoNordisk within their DAWNTM Youth Inrtiative. thi$ prize is for any professional. group
or indivKlual who ha$ made a S￿nIfiCant (r￿MmerCIall innovation Fn pediatric diabetes caie. DAWNT
Youth is a global programme to guide the wider diatletes Community to address the unmet needs of young
people wlh diabetes. their families, peers and healtheare professionals. This prize puls the focus on
diabetes In childhc4)d by reCognis￿9 innovations to improve health and qualty of ￿Te for children and
young people.
Webcasting
The webcasting fund was initsally cwled for costs related lo ISPAD'S fi￿1 wekasling Plafform in 2014
(Annual Conference in Toronto). Since 201 S. ISPAD has a new Conference Resource Plaffomi, for which
the lunding and ￿tated costs are nthv managed as part of the conference budget, managed by K.l.T
Gre￿p. in dose collaboration wrth ISPAD.
E-Learning
New educational tods include Ihe web based e4eaming progfams. These allow a wider access to
infomiation and a conlinw)us auto evaluatK)n. ISPAD has been invited by ESPE to develop the Diabetes
Module in the e-leaming portal created by the team of ProfesSOT Sten Drop in Rotterdam. This Oiabeles
odule will be based on our Clini￿1 Prarti￿ Consensus Guidelines. ISPAD Members wll be able lo
acces5 the frleaming pcKtsI. Dorothy Becker is the kad of the e-leaming project.
The ISPADASPED Lllly diabeles postgraduate coutse
The ISPADIASPEDlilty dk4betes postgraduate course {previousty described as the Post Grad Course
Arabian) is an inrtvalive from ASPED In collaboration with ISPAD. The aim of the Coufse is lo empower and
update physicians practicing in the Arab countries who are invofved in the care of young people with
diabetes and is intended to be a platlom to Sh￿ expe￿"Se. ￿search and devekynenl in the field of
diabetes.
JDRF Fellowship
JDRF ha5 Signed a MOU with ISPAD with the aim to award each year for three years starting in 2017, four
grants of $25,000 to award the four best rese3￿h projects submitted by young researchers, who are
ISPAD members, aged 40 or below. The grant coukl be spent in a hosting center of excellence bul also al
Iheir own ¢entw.
Page 29

THE INTERNATIONAL SOCIETY FOR PEDIATrIC AND At)OLESCENT DIABETES
IA Company Limii•d by Guarantwl
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 DECEMBER 2021
15. Stat•mgnt of Funds Icontinugd)
SWEEf Project
The aim of SWEET is to reduce Inequa1rt￿ in access to aThJ quality of p•liatric diabetes care.
Shortcomings and inequalrtie5 in this care are mainty due to the undetying differences in system5, and the
most straightfo￿ard solution to this problem is a nets￿rk of ped￿triC diabetes cenlers worfdwide.
connected through common objectives and slandards. making rt possible to benchmark resources and
results. The SWEET registry was estsblished in 2008 for this purpose. The ISPAD@SWEET initiative
strives to include Centers from the developing wodd. Eli Lilfy gave É30,000 for the first year of the project
lo equally support both smaller and larger centers, in totsl eghl dinics. from developing COUntr￿S to
become respeclivety Center of Reference and ASsoc￿le￿ Centers of SWEET and start up a registry.
Novo NordisklLily SSP 2018
These are funds lo supFort the Sciertt School for Physicpns.
The remaining restricted fijnds are donatK•ns ￿ grants which must be awarded lo ￿div￿l￿a1S.
Hero Award
This award identifies and honours non<k"nician$ from around the have devebped projects with
bToad impact, thus contributing to improwng and transforming the lives of rnany young people with
diabetes. More information can be found hwe. https.'lfv*VMI.ispad.orglpagellSPADHEROAWARD.
Medtronic Guidelines
Development and Publution of ISPAD Guidelines for Chfldren. Adole￿nt and Young people.
Transfers
During the yew ended 30th June 2020 transfers were mède as folknvs".
Transfers lotalry £44.918 to the SSHP, Nairobi and Piize funds as these were only part funded by
restn.cted funds.
Transfers lorfrom the Allan Drash, E-Leaming. JDRF arKI CDIC funds to wrtte off exchange drfferences of
£202 net.
1S. Anatysis of n•t assets between funds
Analysls of fbet assets between fvnds- current period
UnTe5tri¢ted Restri¢tgd
funds
funds
31
31
D•c•mber
December
2021
2021
Total
lund$
31
December
2021
Current assets
Credrtors due wrthin one year
Credrtors due in more than one ypar
1,534,577
{456,448>
{10,268)
85.008
1,619,585
1456,448)
110,2681
Total
1,067.861
85,008
1.152,869
Page 30

THE INTERNATIONAL SOCIETY FOR PEDIATRIC AND ADOLESCENT DIABETES
IA Company Limited by Guarantee)
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 310ECEMBER 2021
15. Anatysis of net assets between funds Icontinuedl
Analysls of nel assets belween funds - pfior period
Unrestncted
fvnds
30 June
2020
Raslricted
funds
30 June
2020
30 June
2020
Current assets
Creditors due within one year
Credi(ors due in more than one year
1.129.116
(252.021)
(33,430)
110.589
{68.3431
1.239, 705
(320,364)
(33.430)
Total
843,665
42.246
885.911
16. Reconciliation of net movement in lunds to net &ish flow from operating activlties
31
Deceffi￿r
2021
30 June
2020
Net In￿Me for th8 period (as per Ststernent of Financial ActNit*sl
266.958
28,458
Adjustments for:
Interest received
Ilncreasell decrease in debtors
Increase in creditors
(870)
18, 621
18,957
1145.850
112,922
Net cash provided by operating activilies
234,030
65, 166
Page 31

THE INTERNATIONAL SOCIETY FOR PEL¥ATRIC AND ADOLESCENT DIABETES
IA Company L#nited by Guarantee)
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 DECEMBER 2021
17. Analysis of cash and Cash equivalents
31
30 June
2020
2021
Cash in hand
1.416,407
1, 182,377
Total cash and cash equivalents
1.416,407
1, 182,377
18. Analysis of changes in nèt debt
At31
December
2021
At 1 July
2020 Cash Ilows
Cash at bank and in hand
1.182.377
234.030
1.416,407
1.182.377
234.030
1.416.407
19. Related party transactions
There were no related paty transactbjns in this per￿ or wrthin the previous year.
Page 32